superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-12-31
- Valid until
- 2024-12-31
- Published
- 2024-02-20
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 10,003,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "AstraZeneca operating income: 8,193,000,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_7E98BE75827B, https://asof.is/claim/clm_7E98BE75827B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm.
APA
AsOf. (2023). AstraZeneca operating income: 8,193,000,000 United States dollar (as of 2023-12-31 (until 2024-12-31)) [Record clm_7E98BE75827B]. Retrieved November 8, 2026, from https://asof.is/claim/clm_7E98BE75827B (source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm)
BibTeX
@misc{asof_clm_7E98BE75827B,
author = {AsOf},
title = {AstraZeneca operating income: 8,193,000,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_7E98BE75827B}},
note = {Claim clm\_7E98BE75827B, as of 2023-12-31 (until 2024-12-31); source: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_7E98BE75827B.md/v1/claims/clm_7E98BE75827Bsubmit a correction